Europe Gastric Cancer Diagnostic Procedure Market
Historic Data:    |   Base Year: 2023   |   Forecast Period: 2024-2031
Forecast to 2028 - COVID-19 Impact and Regional Analysis By Healthcare Providers (Diagnostic Laboratories, Hospitals, Cancer Research Institutes, Oncology Specialty Clinics, and Others), Symptom Types (Symptomatic and Asymptomatic), Body Fluid (Blood, Urine, Saliva, Stomach Wash/Gastric Juice, Tissue, and Others), Procedures (Endoscopic Procedures, Biopsy & Tissue Tests, Lab Tests, In-Vitro Diagnostic Tests, Imaging Tests, Molecular Diagnostics, Multiplexing Molecular Diagnostics & Immunoassays, and Others), Offering [Instruments, Reagents & Consumables (Including Kits), and Services], Disease Indication (Early Gastric Cancer and Advanced Gastric Cancer), and Country

No. of Pages: 233    |    Report Code: BMIRE00028555    |    Category: Life Sciences

Available Report Formats

pdf-format excel-format pptx-format
Request Free Sample Buy Now
Europe Gastric Cancer Diagnostic Procedure Market
Free Sample Buy Now

1. Introduction

1.1 Business Market Insights Research Report Guidance
1.2 Market Segmentation

2. Executive Summary

2.1 Key Market Insights
2.2 Market Attractiveness

3. Research Methodology

3.1 Secondary Research
3.2 Primary Research
  • 3.2.1 Hypothesis formulation:
  • 3.2.2 Macro-economic factor analysis:
  • 3.2.3 Developing base number:
  • 3.2.4 Data Triangulation:
  • 3.2.5 Country level data:

4. Europe Gastric Cancer Diagnostic Procedure Market Landscape

4.1 Market Overview
4.2 Porter's Five Forces Analysis
  • 4.2.1 Bargaining Power of Suppliers
  • 4.2.2 Bargaining Power of Buyers
  • 4.2.3 Threat of New Entrants
  • 4.2.4 Competitive Rivalry
  • 4.2.5 Threat of Substitutes
4.3 Ecosystem Analysis
  • 4.3.1 Raw Material Suppliers
  • 4.3.2 Manufacturers
  • 4.3.3 Distributors/Suppliers
  • 4.3.4 End Users

5. Europe Gastric Cancer Diagnostic Procedure Market – Key Market Dynamics

5.1 Growth Drivers
  • 5.1.1 Increase in gastric cancer incidence
  • 5.1.2 Advancements in diagnostic technologies
  • 5.1.3 Rising demand for early cancer detection
5.2 Market Opportunities
  • 5.2.1 Rising focus on early detection and diagnostics for gastric cancer
  • 5.2.2 Growing availability of advanced diagnostic technologies
  • 5.2.3 Increasing adoption of non-invasive diagnostic procedures
5.3 Future Trends
  • 5.3.1 Increased use of non-invasive diagnostic technologies
  • 5.3.2 Advancements in biomarkers for gastric cancer detection
  • 5.3.3 Rising interest in personalized diagnostics for cancer treatment
5.4 Impact of Drivers and Restraints

6. Europe Gastric Cancer Diagnostic Procedure Market Regional Analysis

6.1 Europe Gastric Cancer Diagnostic Procedure Market Overview
6.2 Europe Gastric Cancer Diagnostic Procedure Market Revenue 2020-2028 (US$ Million)
6.3 Europe Gastric Cancer Diagnostic Procedure Market Forecast Analysis

7. Europe Gastric Cancer Diagnostic Procedure Market Analysis – by Healthcare Providers

7.1 Diagnostic Laboratories
  • 7.1.1 Overview
  • 7.1.2 Diagnostic Laboratories: Europe Gastric Cancer Diagnostic Procedure Market – Revenue and Forecast to 2031 (US$ Million)
7.2 Hospitals
  • 7.2.1 Overview
  • 7.2.2 Hospitals: Europe Gastric Cancer Diagnostic Procedure Market – Revenue and Forecast to 2031 (US$ Million)
7.3 Cancer Research Institutes
  • 7.3.1 Overview
  • 7.3.2 Cancer Research Institutes: Europe Gastric Cancer Diagnostic Procedure Market – Revenue and Forecast to 2031 (US$ Million)
7.4 Oncology Specialty Clinics
  • 7.4.1 Overview
  • 7.4.2 Oncology Specialty Clinics: Europe Gastric Cancer Diagnostic Procedure Market – Revenue and Forecast to 2031 (US$ Million)

8. Europe Gastric Cancer Diagnostic Procedure Market Analysis – by Symptom Types

8.1 Symptomatic and Asymptomatic
  • 8.1.1 Overview
  • 8.1.2 Symptomatic and Asymptomatic: Europe Gastric Cancer Diagnostic Procedure Market – Revenue and Forecast to 2028 (US$ Million)

9. Europe Gastric Cancer Diagnostic Procedure Market Analysis – by Body Fluid

9.1 Blood
  • 9.1.1 Overview
  • 9.1.2 Symptomatic and Asymptomatic: Europe Gastric Cancer Diagnostic Procedure Market – Revenue and Forecast to 2028 (US$ Million)
9.2 Urine
  • 9.2.1 Overview
  • 9.2.2 Symptomatic and Asymptomatic: Europe Gastric Cancer Diagnostic Procedure Market – Revenue and Forecast to 2028 (US$ Million)
9.3 Saliva
  • 9.3.1 Overview
  • 9.3.2 Symptomatic and Asymptomatic: Europe Gastric Cancer Diagnostic Procedure Market – Revenue and Forecast to 2028 (US$ Million)
9.4 Stomach Wash/Gastric Juice
  • 9.4.1 Overview
  • 9.4.2 Symptomatic and Asymptomatic: Europe Gastric Cancer Diagnostic Procedure Market – Revenue and Forecast to 2028 (US$ Million)
9.5 Tissue
  • 9.5.1 Overview
  • 9.5.2 Symptomatic and Asymptomatic: Europe Gastric Cancer Diagnostic Procedure Market – Revenue and Forecast to 2028 (US$ Million)

10. Europe Gastric Cancer Diagnostic Procedure Market – Europe Analysis

10.1 Europe
  • 10.1.1 Europe Gastric Cancer Diagnostic Procedure Market Breakdown, by Key Country, 2023 and 2028 (%)
  • 10.1.1.1 Europe Gastric Cancer Diagnostic Procedure Market – Revenue and Forecast Analysis – by Country
  • 10.1.1.1 UK: Europe Gastric Cancer Diagnostic Procedure Market – Revenue and Forecast to 2028 (US$ Million)
    • 10.1.1.1.1 UK: Europe Gastric Cancer Diagnostic Procedure Market Breakdown, by Healthcare Providers
    • 10.1.1.1.2 UK: Europe Gastric Cancer Diagnostic Procedure Market Breakdown, by Symptom Types
    • 10.1.1.1.3 UK: Europe Gastric Cancer Diagnostic Procedure Market Breakdown, by Body Fluid
  • 10.1.1.2 Germany: Europe Gastric Cancer Diagnostic Procedure Market – Revenue and Forecast to 2028 (US$ Million)
    • 10.1.1.2.1 Germany: Europe Gastric Cancer Diagnostic Procedure Market Breakdown, by Healthcare Providers
    • 10.1.1.2.2 Germany: Europe Gastric Cancer Diagnostic Procedure Market Breakdown, by Symptom Types
    • 10.1.1.2.3 Germany: Europe Gastric Cancer Diagnostic Procedure Market Breakdown, by Body Fluid
  • 10.1.1.3 France: Europe Gastric Cancer Diagnostic Procedure Market – Revenue and Forecast to 2028 (US$ Million)
    • 10.1.1.3.1 France: Europe Gastric Cancer Diagnostic Procedure Market Breakdown, by Healthcare Providers
    • 10.1.1.3.2 France: Europe Gastric Cancer Diagnostic Procedure Market Breakdown, by Symptom Types
    • 10.1.1.3.3 France: Europe Gastric Cancer Diagnostic Procedure Market Breakdown, by Body Fluid
  • 10.1.1.4 Russia: Europe Gastric Cancer Diagnostic Procedure Market – Revenue and Forecast to 2028 (US$ Million)
    • 10.1.1.4.1 Russia: Europe Gastric Cancer Diagnostic Procedure Market Breakdown, by Healthcare Providers
    • 10.1.1.4.2 Russia: Europe Gastric Cancer Diagnostic Procedure Market Breakdown, by Symptom Types
    • 10.1.1.4.3 Russia: Europe Gastric Cancer Diagnostic Procedure Market Breakdown, by Body Fluid
  • 10.1.1.5 Italy: Europe Gastric Cancer Diagnostic Procedure Market – Revenue and Forecast to 2028 (US$ Million)
    • 10.1.1.5.1 Italy: Europe Gastric Cancer Diagnostic Procedure Market Breakdown, by Healthcare Providers
    • 10.1.1.5.2 Italy: Europe Gastric Cancer Diagnostic Procedure Market Breakdown, by Symptom Types
    • 10.1.1.5.3 Italy: Europe Gastric Cancer Diagnostic Procedure Market Breakdown, by Body Fluid
  • 10.1.1.6 Rest of Europe: Europe Gastric Cancer Diagnostic Procedure Market – Revenue and Forecast to 2028 (US$ Million)
    • 10.1.1.6.1 Rest of Europe: Europe Gastric Cancer Diagnostic Procedure Market Breakdown, by Healthcare Providers
    • 10.1.1.6.2 Rest of Europe: Europe Gastric Cancer Diagnostic Procedure Market Breakdown, by Symptom Types
    • 10.1.1.6.3 Rest of Europe: Europe Gastric Cancer Diagnostic Procedure Market Breakdown, by Body Fluid

11. Competitive Landscape

11.1 Heat Map Analysis
11.2 Company Positioning and Concentration

12. Europe Gastric Cancer Diagnostic Procedure Market Industry Landscape

12.1 Overview
12.2 Mergers and Acquisitions
12.3 Agreements, Collaborations, and Joint Ventures
12.4 New Product Launches
12.5 Expansions and Other Strategic Developments

13. Company Profiles

13.1 Agilent Technologies Inc
  • 13.1.1 Key Facts
  • 13.1.2 Business Description
  • 13.1.3 Products and Services
  • 13.1.4 Financial Overview
  • 13.1.5 SWOT Analysis
  • 13.1.6 Key Developments
13.2 Atlas-Link Biotech Co Ltd
  • 13.2.1 Key Facts
  • 13.2.2 Business Description
  • 13.2.3 Products and Services
  • 13.2.4 Financial Overview
  • 13.2.5 SWOT Analysis
  • 13.2.6 Key Developments
13.3 BioMerieux SA
  • 13.3.1 Key Facts
  • 13.3.2 Business Description
  • 13.3.3 Products and Services
  • 13.3.4 Financial Overview
  • 13.3.5 SWOT Analysis
  • 13.3.6 Key Developments
13.4 Bio-Rad Laboratories Inc
  • 13.4.1 Key Facts
  • 13.4.2 Business Description
  • 13.4.3 Products and Services
  • 13.4.4 Financial Overview
  • 13.4.5 SWOT Analysis
  • 13.4.6 Key Developments
13.5 F. Hoffmann-La Roche Ltd
  • 13.5.1 Key Facts
  • 13.5.2 Business Description
  • 13.5.3 Products and Services
  • 13.5.4 Financial Overview
  • 13.5.5 SWOT Analysis
  • 13.5.6 Key Developments
13.6 Illumina Inc
  • 13.6.1 Key Facts
  • 13.6.2 Business Description
  • 13.6.3 Products and Services
  • 13.6.4 Financial Overview
  • 13.6.5 SWOT Analysis
  • 13.6.6 Key Developments
13.7 MiRXES Pte Ltd
  • 13.7.1 Key Facts
  • 13.7.2 Business Description
  • 13.7.3 Products and Services
  • 13.7.4 Financial Overview
  • 13.7.5 SWOT Analysis
  • 13.7.6 Key Developments
13.8 Myraid Genetics Inc
  • 13.8.1 Key Facts
  • 13.8.2 Business Description
  • 13.8.3 Products and Services
  • 13.8.4 Financial Overview
  • 13.8.5 SWOT Analysis
  • 13.8.6 Key Developments
13.9 Thermo Fisher Scientific Inc
  • 13.9.1 Key Facts
  • 13.9.2 Business Description
  • 13.9.3 Products and Services
  • 13.9.4 Financial Overview
  • 13.9.5 SWOT Analysis
  • 13.9.6 Key Developments
13.10 Vela Diagnostics Holding Pte Ltd
  • 13.10.1 Key Facts
  • 13.10.2 Business Description
  • 13.10.3 Products and Services
  • 13.10.4 Financial Overview
  • 13.10.5 SWOT Analysis
  • 13.10.6 Key Developments

14. Appendix

14.1 About Business Market Insights

The List of Companies - E Market

  1. Agilent Technologies Inc
  2. Atlas-Link Biotech Co Ltd
  3. BioMerieux SA
  4. Bio-Rad Laboratories Inc
  5. F. Hoffmann-La Roche Ltd
  6. Illumina Inc
  7. MiRXES Pte Ltd
  8. Myraid Genetics Inc
  9. Thermo Fisher Scientific Inc
  10. Vela Diagnostics Holding Pte Ltd
europe-gastric-cancer-diagnostic-procedure-market